LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY

被引：0

作者：

Kivitz, A. ^{[1
]}

Wells, A. F. ^{[2
]}

Vargas, J. Ignacio ^{[3
]}

Baraf, H. S. B. ^{[4
,5
]}

Rischmueller, M. ^{[6
,7
,8
]}

Klaff, J. ^{[9
]}

Khan, N. ^{[9
]}

Li, Y. ^{[9
]}

Carter, K. ^{[9
]}

Friedman, A. ^{[9
]}

Durez, P. ^{[10
]}

机构：

[1] Altoona Ctr Clin Res, Altoona Arthrit Osteoporosis Ctr, Duncansville, PA USA

[2] Aurora Rheumatol & Immunotherapy Ctr, Dept Rheumatol, Franklin, WI USA

[3] Quantum Res, Med, Las Lagos, Chile

[4] Ctr Rheumatol & Bone Res, Rheumatol, Wheaton, MD USA

[5] George Washington Univ, Rheumatol, Washington, DC USA

[6] Queen Elizabeth Hosp, Dept Rheumatol, Woodville, SA, Australia

[7] Basil Hetzel Inst, Rheumatol Res Grp, Woodville, SA, Australia

[8] Univ Adelaide, Adelaide Med Sch, Rheumatol, Adelaide, SA, Australia

[9] AbbVie Inc, Immunol, N Chicago, IL USA

[10] UCLouvain St Luc, Inst Rech Experimentale & Clin Univ St Luc, Brussels, Belgium

来源：

关键词：

D O I：

10.1136/annrheumdis-2022-eular.1819

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0685

引用

页码：620 / 621

页数：2